First Quarter Highlights ● Revenue of $40.4 million, down 5.7% year-over-year (7.3% on a constant currency basis)● Gross margin grew to 24.6%, a 270 bps...
Gainers TransCode Therapeutics, Inc. (NASDAQ: RNAZ) shares jumped 308% to $2.71 after the company announced pre-clinical gliblastoma results with its lead candidate, TTX-MC138.
The following are some of the stocks making big moves in Thursday's pre-market trading. Murphy Canyon Acquisition Corp. (MURF) tops with gains of more than 30%. Avinger is the greatest laggard with a decline of more than 11%.
Revenue of $264 million, a decline of 5.4% from Q3 2021Net loss of $85 millionExela’s European business signed a deal to go public through a merger with CF...
NEW YORK, Oct. 17, 2022 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or... | October 17, 2022